A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India

N/ACompletedNCT01351922

Novo Nordisk A/S12,000 enrolled

Overview

This study is conducted in Asia. The aim of this observational study is to evaluate the current status of diabetes management, control, and complications in diabetic subjects in India. Perceptions and practices of physicians and subjects about diabetes management will also be evaluated.

Study Type

OBSERVATIONAL

Enrollment

12,000

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Interventions

No treatment givenOTHER

Patients will fill out a questionaire by interview.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit * First twenty patients of diabetes visiting the centre during the data collection period * Patients willing to sign the informed consent form Exclusion Criteria: * Repetition of any patient as patients should not be included twice for any reason * Unwilling to participate or unable to comply with protocol requirements

Locations (1)

Novo Nordisk Investigational Site

Bangalore, India

Outcomes

Primary Outcomes

Mean age of onset of type 1 diabetes mellitus

Time frame: Evaluation visit

Mean age of onset of type 2 diabetes mellitus

Time frame: Evaluation visit

Mean duration of treatment of type 2 diabetes mellitus

Time frame: Evaluation visit

Percentage of patients on Insulin therapy

Time frame: Evaluation visit

Percentage of patients on Oral Anti-Diabetics Drug (OADs) therapy

Time frame: Evaluation visit

Mean duration of diabetes in type 1 patients

Time frame: Evaluation visit

Mean duration of diabetes in type 2 patients

Time frame: Evaluation visit

Mean FPG (fasting plasma glucose)

Time frame: Evaluation visit

PPG (post prandial glucose)

Time frame: Evaluation visit

HbA1c (Glycosylated Haemoglobin)

Time frame: Evaluation visit

Percentage of patients archiving HbA1c target below or equal 6.5%

Time frame: Evaluation visit

Percentage of patients archiving HbA1c target below or equal 7.0%

Time frame: Evaluation visit

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.